Revolune Launches Service Provider Program with Key Partners

Revolune, based in Oberkochen, Germany, announced its new Service Provider Program, partnering with CellCarta, Concept Life Sciences, and Propath UK. This initiative aims to broaden access to Revolune's multiplex immunofluorescence (mIF) workflows through experienced laboratories, aiding researchers and translational teams in exploring and scaling these technologies.

The program targets customers lacking the infrastructure for advanced multiplex IF capabilities, allowing them to leverage the expertise of service providers. Revolune's CEO, Florian Leiss, emphasized the flexibility offered through this program, facilitating both outsourced execution and internal development of capabilities.

Partners bring unique strengths: CellCarta offers precision medicine and biomarker services; Concept Life Sciences excels in discovery and development services; and Propath UK provides expertise in spatial biology and tissue-based biomarkers. This collaboration marks a strategic move in Revolune’s goal to enhance the adoption of their adaptable multiplex staining technology.